Quick Stats for Obesity GLP-1 Market Obesity GLP-1 Market Value (2025): USD 8,169 million Obesity GLP-1 Market Forecast Value (2035): USD 65,364 million Obesity GLP-1 Market Forecast CAGR: 23.1% Leading Molecule Class in Obesity GLP-1 Market: Semaglutide (58.0%) Key Growth Regions in Obesity GLP-1 Market: North America, Europe, and East Asia Top Key Players in Obesity GLP-1 Market: Novo Nordisk, Eli Lilly, and emerging manufacturers Between 2025 and 2030, the obesity GLP-1 market is projected to expand from USD 8169.0 million to USD 39,528 million, resulting in a value increase of USD 31359.0 million, which represents 54.8% of the total forecast growth for the decade
You can try using an app or a log to keep track of how much water youre drinking, or carry a large, refillable bottle with you throughout your day, as a few strategies to keep hydration from falling under the radar
Buy Retatrutide 10mg, 20mg, or 30mg in Bangkok & nationwide Thailand
The short answer: some lean mass loss occurs, as it does with any caloric deficit, but the proportion is better than diet-alone approaches
This prevents atmospheric moisture from condensing on the cold powder, which could lead to instant hydrolysis
Revenue also missed Wall Street analysts' expectations